HCPLive Network

Bone Loss Drugs Increase Stroke Risk in Patients with Cancer

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk for atrial fibrillation and stroke. According to a study published online in the Journal of Clinical Oncology, the absolute risk for these patients within 6 years of starting bisphosphonate treatment was approximately 8% for all supraventricular tachycardia events and 4% for stroke.

Article courtesy of http://www.onclive.com
 



Further Reading
Magnetic resonance is an effective alternative to biopsy for identifying and quantifying fats in the liver, according to results from a study led by a research team at the University of the Basque Country.
The presence of other health care workers improves hand hygiene adherence, according to a study published in the October issue of Infection Control and Hospital Epidemiology.
For patients with breast cancer with spinal metastases, estrogen receptor/hormone receptor-negative status is associated with worse survival, according to a study published in the Sept. 1 issue of Spine.
Less than half of all Americans got a flu shot last year, so U.S. health officials on Thursday urged that everyone 6 months and older get vaccinated for the coming flu season. "It's really unfortunate that half of Americans are not getting the protection from flu they could get," said Thomas Frieden, MD, director of the U.S. Centers for Disease Control and Prevention, during a morning news conference.
Just a single dose of a common antidepressant can quickly alter the way brain cells communicate with one another, according to early research published online Sept. 18 in Current Biology.
The investigational drug alpelisib (previously known as BYL719) appears to inhibit activation of the pathway that leads to resistance to cetuximab, an anti-epidermal growth factor receptor agent used in the treatment of head and neck cancer. These findings were presented at the American Association for Cancer Research's special conference "Targeting the PI3K-mTOR Network in Cancer," held from Sept. 14 to 17 in Philadelphia.
Strategies are presented to help physicians lower their tax burden in an article published Sept. 2 in Medical Economics.
More Reading